Exponent, Inc. (EXPO) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
Key Financial Performance
Total Revenues Increased 8% to $147.1 million year-over-year. This growth was driven by demand for Exponent's risk management and asset integrity management services in the utility industry and disputes related to services in the energy, automotive, and medical device sectors.
Net Revenues Increased 10% to $137.1 million year-over-year. This reflects strong performance across diversified portfolios and industries.
Net Income Increased to $28 million or $0.55 per diluted share, compared to $26 million or $0.50 per diluted share in the prior year period. The increase was supported by better utilization and a strong realized rate increase.
EBITDA Increased 9% to $38.8 million, producing a margin of 28.3% of net revenues compared to $35.8 million or 28.6% of net revenues in the same period of 2024. The slight decrease in margin was due to costs associated with a managers meeting, partially offset by better utilization and a strong realized rate increase.
Billable Hours Approximately 376,000, an increase of 4% year-over-year. This was driven by recruiting and retention efforts.
Average Number of Technical Full-Time Equivalent Employees 976, up 3% year-over-year. This increase was due to recruiting and retention efforts.
Utilization 74.1%, up from 73.4% in the same period of 2024. This reflects improved operational efficiency.
Realized Rate Increase Approximately 6% for the third quarter compared to the same period a year ago. This is attributed to Exponent's premium position in the marketplace, unparalleled talent, and differentiated expertise.
Compensation Expense Increased 8% year-over-year after adjusting for gains and losses in deferred compensation. This includes a gain in deferred compensation of $7 million compared to $7.2 million in the third quarter of 2024.
Stock-Based Compensation Expense $5.3 million, compared to $5.5 million in the prior year period, reflecting a slight decrease.
Other Operating Expenses Increased 6% to $12.7 million. This includes depreciation and amortization expense of $2.5 million for the third quarter.
G&A Expenses Increased 44% to $7.7 million in the third quarter. The increase was primarily due to travel and meals associated with an in-person managers meeting, which did not occur in the prior year.
Interest Income Decreased to $2.3 million for the third quarter, driven by lower interest rates.
Capital Expenditures $2.7 million for the quarter.
Shareholder Distributions $15.1 million distributed through dividend payments and $40 million of common stock repurchased at an average price of $70.45.
Engineering and Other Scientific Segment Net Revenues Represented 84% of net revenues in the third quarter and increased 10%, driven by demand for risk management and asset integrity management services in the utility industry and disputes related to services in the energy, automotive, and medical device sectors.
Environmental and Health Segment Net Revenues Represented 16% of net revenues in the third quarter and increased 9%, due to an increase in regulatory consulting engagements in the chemicals industry.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Human-machine interaction studies: Improving demand trends in consumer electronics, particularly with human-machine interaction studies.
AI integration: Engaged in early-stage initiatives tied to transformative technologies, including AI integrated into safety-critical systems.
Safety-critical systems: Advancing work in evaluating human-machine interaction and safety-critical systems, including advanced medical devices, robotics, and autonomous vehicles.
Energy sector: Increased activity in generation, delivery, and storage due to energy transition initiatives, extreme weather events, and data center growth.
Transportation sector: Rising disputes regarding design and performance of advanced vehicle technologies.
Life sciences: Increased engagements involving complex medical devices focusing on product safety, quality, and performance.
Construction sector: Higher demand for expertise in addressing complex construction challenges and disputes.
Chemicals sector: Strong demand for regulatory consulting related to the impact of chemicals on human health and the environment.
Revenue growth: Net revenues increased by 10% year-over-year to $137.1 million in Q3 2025.
Employee growth: Average number of technical full-time equivalent employees increased by 3% year-over-year.
Utilization rate: Utilization rate improved to 74.1% in Q3 2025 from 73.4% in Q3 2024.
Stock repurchase program: Board approved a $100 million increase in the stock repurchase program.
Talent investment: Focused on recruiting and retention efforts to grow technical staff and foster leadership.
AI and transformative technologies: Positioned to help clients navigate technological disruptions, including AI and safety-critical systems.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Energy Sector Challenges: Increased activity in failure analysis for legacy systems and challenges with new technologies due to energy transition initiatives, extreme weather events, and rapid growth of data centers.
Transportation Sector Risks: Disputes regarding the design and performance of advanced vehicle technologies are becoming more prevalent and complex, with higher consequences of failure.
Life Sciences Sector Risks: Increased scrutiny of product safety, quality, and performance for complex medical devices.
Construction Sector Challenges: Increased demand related to complex construction challenges and disputes.
Consumer Electronics Sector Risks: Lower activity in consumer electronics, though improving demand trends are noted.
Artificial Intelligence Risks: Integration of AI into safety-critical systems introduces new high-consequence failure modes and increased complexity and risk.
Regulatory and Environmental Risks: Demand for regulatory consulting in the chemical sector related to the impact of chemicals on human health and the environment.
Operational Risks: Seasonal lower utilization in the fourth quarter due to holidays and vacations, and increased G&A expenses due to firm-wide meetings.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: For the fourth quarter of 2025, revenues before reimbursements are expected to grow in the low to mid-single digits. For the full year 2025, revenue before reimbursements is expected to grow in the low single digits.
EBITDA Margin: For the fourth quarter of 2025, EBITDA is expected to be 26% to 27% of revenues before reimbursements. For the full year 2025, EBITDA is expected to be 27.4% to 27.65% of revenues before reimbursements.
Utilization: Utilization in the fourth quarter of 2025 is expected to be 68% to 70%, with full-year utilization expected to be approximately 72.5%.
Realized Rate Increase: The realized rate increase is expected to be 4% to 5% for the fourth quarter and full year 2025.
Capital Expenditures: Capital expenditures for the full year 2025 are expected to be $10 million to $12 million.
Tax Rate: The tax rate for the fourth quarter of 2025 is expected to be approximately 28%, with the full year 2025 tax rate expected to be 28.5%.
Stock-Based Compensation Expense: For the fourth quarter of 2025, stock-based compensation expense is expected to be $4.9 million to $5.2 million. For the full year 2025, it is expected to be $23.7 million to $24 million.
Other Operating Expenses: For the fourth quarter of 2025, other operating expenses are expected to be $12.7 million to $13.2 million. For the full year 2025, they are expected to be $49.5 million to $50 million.
G&A Expenses: For the fourth quarter of 2025, G&A expenses are expected to be $6.1 million to $6.6 million. For the full year 2025, they are expected to be $25 million to $25.5 million.
Interest Income: Interest income for the fourth quarter of 2025 is expected to be $1.5 million to $1.8 million.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Payments: Distributed $15.1 million to shareholders through dividend payments in the third quarter of 2025.
Stock Repurchase: Repurchased $40 million of common stock at an average price of $70.45 in the third quarter of 2025.
Stock Repurchase Program Expansion: Board approved a $100 million increase in the current stock repurchase program, in addition to the $21.6 million available for repurchases as of October 3, 2025.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the early thoughts on hiring for 2026?
A:The company is targeting 4% to 6% growth in headcount, focusing on areas like digital health, automated vehicles, and energy. They are planning to return to a more historical range of hiring after trailing in the past year or two.
Q:Can you size the impact of AI on the business and its growth potential?
A:AI is significantly integrated into the business across industries like electronics, medical devices, energy, and automotive. It is used both reactively (e.g., disputes, failure analysis) and proactively (e.g., algorithm training, risk modeling). However, it is difficult to quantify its exact percentage impact.
Q:What is the growth trend between proactive and reactive business year-to-date?
A:The reactive business has been the main growth driver, with 18% growth in Q3, while proactive business was flat. Proactive growth in regulatory consulting and risk management was offset by a decline in consumer electronics hardware work.
Q:How has the regulatory environment evolved under the current administration?
A:Most regulatory work is in chemicals, medical devices, and automotive sectors. There are some delays in feedback from agencies like FDA and EPA, but overall, regulatory enforcement remains strong. The company has also recruited talent from regulatory agencies.
Q:What is the impact of the government shutdown on the business?
A:The company has 2%-3% of its work in federal government contracts, most of which were not paused. Revenues from government work in Q4 are expected to be similar to Q3.
Q:Are there any preliminary thoughts on revenue growth for 2026?
A:The company will provide guidance in early 2026. They are optimistic about growth due to sustained utilization and headcount growth.
Q:How did FTE growth trend between proactive and reactive practices in the quarter?
A:The company does not organize hiring by proactive or reactive practices but by disciplines. Reactive work is driving short-term hiring, while long-term hiring focuses on areas like electrical engineering, computer science, and human-machine interaction.
Q:Is the mix of hiring affecting rate increases, and can the current rate increase of 6% continue?
A:Rate increases have been driven by strong demand, inflationary pressures, and a higher utilization of senior staff. However, as hiring increases and more junior staff are onboarded, rate realization is expected to normalize to 3%-3.5%.
Q:Review of Unclear Management Responses
A:Management avoided providing specific revenue growth guidance for 2026, stating that they are still in the planning process and will provide details in early 2026.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Conference
Consultancy statement
Dr
Exponent company
Exponent digit
Exponent expertise
Exponent risk
Form development
GA increase
Konstantelos Riveron
Riveron Consultancy
Secretary afternoon
ability value
activity consumer
asset integrity
chemical sector
consequence failure
consulting
demand trend
detail
digit revenue
electronics demand
engagement risk
firm
integrity project
life science
machine interaction
opportunity Exponent
project utility
quarter
reactive engagement
repurchase
revenue segment
risk asset
safety system
sector activity
transportation
utilization rate
EXPO Transcript
Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript
Unknown5-1
The earnings report shows modest revenue and income growth with improved operational efficiencies. However, the lack of discussion on strategic initiatives and operational updates, coupled with general forward-looking risks, tempers enthusiasm. The slight improvement in operating margin is positive, but the absence of guidance or new developments keeps the sentiment neutral. Given the company's market cap, the stock is unlikely to experience significant volatility.
Exponent, Inc. (EXPO) Q4 2025 Earnings Call Transcript
Positive2-5
The earnings call reflects a positive outlook with strong operational performance, increased dividends, and stock repurchases. The company is capitalizing on AI, with potential growth in consumer electronics and energy sectors. Despite some unclear management responses, the guidance indicates high single-digit growth, supported by diversification and strong demand. Although interest income decreased, cash from operations and capital allocation priorities remain strong. Given the market cap, the stock is likely to experience a moderate positive movement.
Exponent, Inc. (EXPO) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
Exponent, Inc. (EXPO) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
EXPO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
